Anna Schwendeman
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Immunology top 1%
- Immunotherapy and Immune Responses
Papers in
-
- Protein purification and stability 11
- Immunology 30
- Immunotherapy and Immune Responses 12
- Co-authors
- James J. Moon (28 shared papers)Rui Kuai (19 shared papers)Lukasz J. Ochyl (3 shared papers)Keith S. Bahjat (1 shared paper)Emily E. Morin (15 shared papers)Sejin Son (3 shared papers)Jutaek Nam (4 shared papers)Wenmin Yuan (24 shared papers)
- Journals
- Journal of Controlled Release (11 papers)International Journal of Pharmaceutics (6 papers)Nanomedicine Nanotechnology Biology and Medicine (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (4 papers)Frontiers in Pharmacology (4 papers)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Anna Schwendeman
111 papers receiving 6.1k citations
Anna Schwendeman's Hit Papers
Peers
Comparison fields: 5 of 134
- Biomaterials 1.4k
- Immunology 1.8k
- Pharmaceutical Science 375
- Biomedical Engineering 2.1k
- Oncology 915
Countries citing papers authored by Anna Schwendeman
This map shows the geographic impact of Anna Schwendeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schwendeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schwendeman more than expected).
Fields of papers citing papers by Anna Schwendeman
This network shows the impact of papers produced by Anna Schwendeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schwendeman. The network helps show where Anna Schwendeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Schwendeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Designer vaccine nanodiscs for personalized cancer immunotherapy Hit paper breakdown → | 2016 | 895 |
| 2 | Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer Hit paper breakdown → | 2018 | 704 |
| 3 | Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures Hit paper breakdown → | 2019 | 443 |
| 4 | 2018 | 305 | |
| 5 | 2016 | 292 | |
| 6 | 2019 | 189 | |
| 7 | 2019 | 168 | |
| 8 | 2019 | 155 | |
| 9 | 2020 | 143 | |
| 10 | 2018 | 124 | |
| 11 | 2018 | 114 | |
| 12 | 2020 | 113 | |
| 13 | 2015 | 96 | |
| 14 | 2017 | 84 | |
| 15 | 2015 | 79 | |
| 16 | 2016 | 74 | |
| 17 | 2018 | 74 | |
| 18 | 2020 | 70 | |
| 19 | 2020 | 70 | |
| 20 | 2020 | 67 |
About Anna Schwendeman
Anna Schwendeman is a scholar working on Molecular Biology, Immunology, Surgery, Pharmaceutical Science and Oncology, having authored 115 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (15 papers), Advanced Drug Delivery Systems (13 papers), Immunotherapy and Immune Responses (12 papers), Cancer, Lipids, and Metabolism (12 papers), Protein purification and stability (11 papers), Lipoproteins and Cardiovascular Health (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Biomaterials (1.4k citations), Immunology (1.8k citations), Pharmaceutical Science (375 citations), Biomedical Engineering (2.1k citations) and Oncology (915 citations). Anna Schwendeman has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include James J. Moon, Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat, Emily E. Morin, Sejin Son, Jutaek Nam, Wenmin Yuan, Minzhi Yu and Hongliang He. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine, European Journal of Pharmaceutics and Biopharmaceutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.